The role of the data coordinating center in the DIG trial.
暂无分享,去创建一个
S. Yusuf | W. Williford | D. Egan | J. Collins | R. Garg | F. McSherry | C. L. Howell | A. Horney | G. Kirk | E. Spence | S. Stinnett
[1] Leonard Steinborn,et al. The United States Code of Federal Regulations 21 CFR, Part 211, Current Good Manufacturing Practice for Finished Pharmaceuticals , 2004 .
[2] K. Teo,et al. The role of the data coordinating center in the IRB review and approval process: the DIG trial experience. , 2003, Controlled clinical trials.
[3] D. Egan,et al. The use of regional coordinating centers in large clinical trials: the DIG trial. , 2003, Controlled clinical trials.
[4] E. J. Brown,et al. The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.
[5] S. Yusuf,et al. Selection of patients for randomized controlled trials: implications of wide or narrow eligibility criteria. , 1990, Statistics in medicine.
[6] R Peto,et al. Why do we need some large, simple randomized trials? , 1984, Statistics in medicine.
[7] R. Jelliffe,et al. A nomogram for digoxin therapy. , 1974, The American journal of medicine.